"Designing Growth Strategies is in our DNA"

Computed Tomography (CT) Scanners Market Size, Share & Industry Analysis, By Technology (High Slice, Mid Slice, Low Slice, and Cone Beam Computed Tomography (CBCT)), By Application (Orthopedics, Cardiovascular, Oncology, Neurology, and Others), By Modality (O-arms and C-arms), By End-User (Hospitals & Ambulatory Surgical Centers (ASCs), Diagnostic Imaging Centers, and Others), and Regional Forecast, 2026-2034

Last Updated: July 20, 2026 | Format: PDF | Report ID: FBI104461

 

Buy Now

(Offer valid till 15th Aug 2026)

Computed Tomography (CT) Scanners Market Size and Future Outlook

Play Audio Listen to Audio Version

The global computed tomography (CT) scanners market size was valued at USD 7.80 billion in 2025 and is projected to grow from USD 8.22 billion in 2026 to USD 13.63 billion by 2034, exhibiting a CAGR of 6.5% during the forecast period. Asia Pacific dominated the computed tomography (CT) scanner market with a market share of 44.87% in 2025.

The increasing prevalence of chronic diseases, such as cancer, neurological diseases, cardiovascular diseases, and orthopaedic disorders, has led to a large patient pool requiring diagnostic imaging modalities such as computed tomography and magnetic resonance imaging. The rising burden of these conditions continues to drive demand for early diagnosis.

  • For instance, according to data published by the Centers for Disease Control and Prevention in June 2024, around 16 million people in the U.S. were living with chronic obstructive pulmonary disease (COPD).

Computed tomography is a medical imaging system widely used in healthcare facilities for early detection, diagnosis, and monitoring of various diseases. Continuous technological advancements in the CT imaging segment have further fueled the demand for advanced CT systems across hospitals and diagnostic centers. In addition, the rising installation of new computed tomography (CT) systems for precise disease prognosis across healthcare settings has led to the growth of the global market. Moreover, the surge in investments by public and private organizations toward advanced imaging centers is expected to further boost market growth.

  • For instance, in May 2022, the Royal Free London NHS Foundation Trust invested over USD 1.25 million in a new state-of-the-art CT scanner, Aquilion ONE PRISM, to enhance the speed and accuracy of patient diagnosis.

Key players in the market include Siemens Healthineers AG, GE HealthCare, Canon Medical Systems Corporation, and Koninklijke Philips. These players are focusing on inorganic growth strategies such as partnerships and collaborations to boost their share in the market.

Computed Tomography (CT) Scanner Market

Download Free sample to learn more about this report.

CT Scanners Market Takeaways

trending up Global Market Size & Forecast
  • 2025 Market Size: USD 7.80 billion
  • 2026 Market Size: USD 8.22 billion
  • 2034 Forecast Market Size: USD 13.63 billion
  • CAGR: 6.5% from 2026–2034
globe Market Share
  • Asia Pacific accounted for the largest market share in 2024, valued at USD 3.29 billion, and maintained its leading position in 2025 with USD 3.50 billion.
  • The low slice segment held the largest global computed tomography (CT) scanners market share in 2025.
  • The oncology segment held a dominant share of the market in 2025 and is estimated to hold a 31.4% share in 2026.
flag Key Regional Highlights

Asia Pacific

Asia Pacific accounted for the largest market share in 2024, valued at USD 3.29 billion, and maintained its leading position in 2025 with USD 3.50 billion.

North America

The North America market is projected to reach approximately USD 1.70 billion in 2026, making it the second-largest regional market worldwide.

Europe

Europe is projected to record a CAGR of 5.6% during the forecast period, making it the third-fastest-growing regional market. The market is expected to reach USD 1.40 billion in 2026.

U.S.

In 2026, the U.S. is anticipated to reach USD 1.62 billion, accounting for approximately 19.7% of the global sales.

Japan

The Japanese market is projected to reach USD 0.95 billion in 2026, representing nearly 11.6% of the global sales.

Read More

arrow btn

Growing Adoption of Artificial Intelligence and Photon-Counting CT Technology to Boost Industry Expansion

The computed tomography (CT) scanners market is evolving rapidly with the adoption of AI-enabled imaging and photon-counting CT technology, driven by the need for higher diagnostic accuracy, lower radiation exposure, and improved workflow efficiency. Photon-counting CT represents a major technological advancement, offering superior spatial resolution, enhanced tissue characterization, and improved spectral imaging compared to conventional CT systems. For instance, Siemens Healthineers pioneered this segment with the FDA-cleared NAEOTOM Alpha in March 2025, while GE HealthCare expanded competition by receiving FDA 510(k) clearance for Photonova Spectra in March 2026.

Alongside detector innovation, AI is becoming an integral component of modern CT systems. AI-powered image reconstruction and workflow solutions reduce image noise, improve image quality, optimize radiation dose, and accelerate scan processing. These capabilities enable radiology departments to manage increasing imaging volumes while enhancing diagnostic consistency and operational efficiency. As healthcare providers continue to invest in advanced imaging technologies, the adoption of AI-enabled and photon-counting CT systems is expected to accelerate during the study period.

MARKET DYNAMICS

MARKET DRIVERS

Download Free sample to learn more about this report.

Rising Burden of Cancer, Cardiovascular Diseases, Neurological Disorders, and Traumatic Injuries Drives Product Demand

Computed tomography (CT) scanners play a critical role in the diagnosis, monitoring, and treatment planning of numerous medical conditions, including cardiovascular diseases, cancer, neurological disorders, respiratory diseases, and traumatic injuries. As the global burden of these diseases continues to rise, healthcare providers are increasingly relying on advanced diagnostic imaging technologies to support early disease detection and improved patient outcomes. CT imaging is widely used for coronary artery assessment, cardiac function evaluation, and vascular imaging, making it an essential diagnostic tool for managing cardiovascular conditions. The growing prevalence of stroke and neurovascular disorders has increased demand for advanced CT systems capable of delivering rapid and accurate diagnostic information in emergency settings. In addition, the growing incidence of cancer continues to drive CT scanner utilization for treatment planning.

  • For instance, according to the International Agency for Research on Cancer (IARC) in February 2024, global cancer incidence exceeded 20 million new cases annually, with the number expected to increase significantly over the coming years.

CT imaging is routinely used throughout the oncology care pathway, including cancer screening, tumor localization, treatment planning, and post-treatment monitoring. Moreover, the growing adoption of lung cancer screening programs in several countries has further strengthened demand for advanced CT imaging technologies. This trend is anticipated to drive the global computed tomography (CT) scanners market growth during the forecast period.

Rank

Market Driver

Overall Impact Rank

CAGR Contribution (2026-2034)

Impact: 2026-2028

Impact: 2029-2031

Impact: 2032-2034

1

Rising Burden of Cancer, Cardiovascular Diseases, Neurological Disorders and Traumatic Injuries

High

+2.20%

High

High

High

2

Increasing Adoption of Advanced CT Technologies (Photon-counting CT, AI-enabled Reconstruction and Spectral CT)

Medium-High

+1.70%

High

High

High

3

Expansion of Hospital Infrastructure, Diagnostic Imaging Centers and Healthcare Investments in Emerging Markets

Medium-High

+1.35%

High

High

Medium

4

Growing Preference for Early Disease Detection, Preventive Health Screening and Image-guided Clinical Decision Making

Medium

+1.05%

Medium

Medium

High

5

Rising Demand for High-throughput Emergency, Cardiac and Oncology Imaging with Faster Workflow Efficiency

Medium-Low

+0.80%

Medium

Medium

Low

6

Others (Replacement of aging CT systems, favorable reimbursement in developed markets, mobile CT adoption, expanding clinical applications and technological upgrades)

Low

+0.55%

Low

Lowm

Low

 

Total Positive Growth Contribution

 

+7.65%

     

MARKET RESTRAINTS

High Maintenance and Installation Costs of Medical Imaging Systems May Hinder Market Growth

The high maintenance and installation cost of medical imaging equipment are among the major factors poised to hamper the global computed tomography (CT) scanners market during the forecast period.

  • For instance, according to an article published by Excedr in June 2023, the acquisition cost of a 16-slice computed tomography system ranges from USD 285,000 to USD 360,000.

In addition, the annual maintenance cost of a 16-slice basic scanner is around USD 60,000, while that of a high-end 128 Slice scanner reaches around USD 250,000. These high maintenance costs can make advanced CT systems unaffordable for small-sized healthcare facilities. Moreover, the limited availability of comprehensive medical equipment maintenance policies and lack of qualified technical staff hamper the adoption of new devices across healthcare industries.

Rank

Market Restraint

Overall Impact Rank

Negative CAGR Contribution (2026-2034)

Impact: 2026-2028

Impact: 2029-2031

Impact: 2032-2034

1

High Installation and Maintenance Cost of CT systems

High

-0.55%

High

High

HIgh

2

Concerns Regarding Radiation Exposure and Preference for Alternative Imaging Modalities in Selected Clinical Applications

Medium

-0.30%

Medium

Medium

Medium

3

Shortage of Skilled Radiologists and CT Technologists, Particularly in Developing Regions

Medium-Low

-0.20%

Medium

Medium

Low

4

Others (Lengthy procurement cycles, budget constraints, regulatory compliance costs and supply-chain disruptions)

Low

-0.10%

Low

Low

Low

 

Total Negative Growth Impact

 

-1.15%

     

MARKET OPPORTUNITIES

Growing Emphasis on Preventive Care and Early Diagnosis Creates New Growth Opportunities

The growing emphasis on preventive healthcare and early diagnosis presents a significant opportunity for the CT scanners market. With the rising incidence of chronic diseases such as cardiovascular disorders, cancer, and neurological disorders, healthcare providers are increasingly adopting advanced diagnostic modalities to enable timely and accurate detection. This shift is driving demand for next-generation CT scanners capable of providing high-resolution imaging with reduced radiation exposure.

  • For instance, in October 2024, UC Davis Health announced the installation of a new state-of-the-art cardiovascular CT scanner, enabling high-quality cardiac imaging with shorter scan and turnaround times.

Furthermore, ongoing technological advancements, coupled with increasing government initiatives and healthcare providers' efforts to expand disease screening programs, are estimated to create a favorable environment for market growth during the forecast period.

  • For instance, in February 2024, the National Institute of Health (NIH) launched the Cancer Screening Research Network to evaluate emerging cancer screening technologies, including multi-cancer detection blood tests. As a result, more patients with positive or suspicious screening results may require confirmatory imaging, tumor localization, staging, and treatment planning, driving adoption of CT scanners.

MARKET CHALLENGES

Stringent Regulatory Requirements and Radiation Safety Concerns Challenge Market Growth

One of the critical challenges facing the CT scanners market is the growing scrutiny from regulatory authorities concerning patient safety and radiation exposure. Despite significant technological progress aimed at reducing radiation doses, concerns regarding the cumulative radiation exposure associated with repeated CT scans continue to draw regulatory and public attention.

  • For instance, according to a study published by UC San Francisco in April 2025, CT scans are responsible for 5% of cancer cases per year across the U.S.

This has led to stricter guidelines governing the appropriate use of CT imaging, particularly for pediatric and vulnerable patient groups, leading to restrained utilization in certain healthcare settings. Moreover, market players are required to ensure their devices meet stringent quality, safety, and performance benchmarks mandated by agencies such as the FDA, CE, and local health ministries. Adapting to these regulatory pressures while ensuring innovation and market competitiveness remains a persistent challenge for industry stakeholders.

Segmentation Analysis

By Technology

Well-Established Product Portfolio of Market Players Fueled Low Slice Segment Growth

By technology, the global market is divided into high slice, mid slice, low slice, and cone beam computed tomography (CBCT).

The low slice segment held the largest global computed tomography (CT) scanners market share in 2025. This segment’s growth is primarily driven by the increasing use of low slice scanners in emerging countries, the well-established product portfolio of market players, and the new product launches in this segment.

Moreover, the high adoption of low-slice scanners in diagnosing several chronic disorders, such as cancer, and the low costs of these devices compared to high-end devices have been instrumental in augmenting the demand for low-slice products globally.

  • According to data published by Humber and North Yorkshire Cancer Alliance in March 2023, a low-slice CT scan helps identify potential lung problems, including lung cancer, at an earlier stage, assessing early disease diagnosis.

To know how our report can help streamline your business, Speak to Analyst

The mid slice segment is projected to grow at a CAGR of 5.7% during the forecast period.

By Application

Continuous Introduction of Advanced Imaging Systems Impelled Oncology Segment Growth

In terms of application, the market is segmented into orthopedics, cardiovascular, oncology, neurology, and others.

The oncology segment held a dominant share of the market in 2025. The increasing cancer prevalence globally and the rise in the adoption of CT scanners in cancer diagnostics are significant factors boosting the segment's growth. Moreover, the continuous introduction of advanced imaging systems by market players for oncology applications has propelled the growth of the segment. The segment is estimated to hold a 31.4% share in 2026.

  • For instance, in February 2023, Siemens Healthineers AG launched the Biograph Vision.X PET/CT scanner at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) annual meeting. The system combines diagnostic and therapeutic capabilities to support the treatment of post-recurrent prostate cancer patients.

The neurology segment is expected to grow at a CAGR of 6.0% during the forecast period.

By Modality

High Adoption of O-Arms across Healthcare Settings Boosted Segment Growth

By modality, the market is segregated into O-arms and C-arms.

The O-arms segment held the largest share in the global market in 2025. The rise in the patient pool for diagnostic CT scan procedures and the rising adoption of these devices across healthcare settings have boosted the segment's growth. Moreover, potential advantages of these systems, such as enhanced visualization, seamless navigation, and improved accuracy, further propelled segment growth. The segment is projected to hold a 67.8% share in 2026.

  • For instance, in February 2023, Sparsh Health and Sita Bhateja Hospital completed 100 complex spine surgeries using an O-arm surgical imaging system with the StealthStation S8 Navigation system in India.

The C-arms segment is expected to grow at a higher CAGR of 7.4% during the forecast period.

By End-User

Hospitals & Ambulatory Surgical Centers (ASCs) Segment Dominated Due to Well-Established Healthcare Sector in Developed Regions

On the basis of end user, the market is segmented into hospitals & ambulatory surgical centers (ASCs), diagnostic imaging centers, and others.

The hospitals & ambulatory surgical centers (ASCs) segment held the dominant market share in the end-user segment in 2025. The well-established healthcare sector in developed regions, the growing number of hospitals in developing countries, and the increasing number of CT imaging examinations at hospitals and ambulatory surgical centers (ASCs) are slated to boost the segment growth during the forecast period. The segment is projected to hold a 60.1% share in 2026.

  • For instance, as per OECD statistics, in December 2024, a total of 177 computed tomography scans per 1000 individuals were performed in hospitals in Australia in the same year, compared to 167 per 1000 in 2023.

The diagnostic imaging centers segment is anticipated to grow at a CAGR of 6.8% during the forecast period.

Computed Tomography (CT) Scanners Market Regional Outlook

Based on region, the market is segmented into North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa.

Asia Pacific

Asia Pacific Computed Tomography (CT) Scanners Market Size, 2025 (USD Billion)

To get more information on the regional analysis of this market, Download Free sample

Asia Pacific accounted for the largest market share in 2024, valued at USD 3.29 billion, and maintained its leading position in 2025 with USD 3.50 billion. The region’s dominance is due to the increasing incidence of chronic diseases, the developing healthcare sector, and strong unmet need for advanced diagnostic systems across diagnostic centers. In addition, the region has a large and aging installed base of CT scanners, offering enormous potential for new systems in this region. In addition, extensive investments by market players to expand their presence in the region are also projected to have a positive impact on market growth.

  • For instance, in June 2025, GE HealthCare and PT Kalbe Farma Tbk announced the opening of Indonesia’s first CT scanner manufacturing facility in Bogor. The facility is anticipated to strengthen the country’s local production and improve access to diagnostic imaging technologies.

Japan Computed Tomography (CT) Scanners Market

The Japanese market is projected to reach USD 0.95 billion in 2026, representing nearly 11.6% of the global sales.

China Computed Tomography (CT) Scanners Market

The Chinese market is anticipated to reach around USD 1.60 billion in 2026, accounting for nearly 19.5% of the global revenues.

India Computed Tomography (CT) Scanners Market

The Indian market is expected to reach approximately USD 0.23 billion in 2026, accounting for around 2.8% of the global revenues.

North America   

The North America market is projected to reach approximately USD 1.70 billion in 2026, making it the second-largest regional market worldwide. The increasing number of patients undergoing diagnostic imaging procedures in the region and the rise in the introduction of technologically advanced systems across the U.S. healthcare settings have propelled the market's growth in this region.

  • For instance, in September 2022, the Mayo Foundation for Medical Education and Research (MFMER) installed the Biograph Vision Quadra PET/CT scanner to improve imaging quality and scanning speed, especially for the diagnosis and treatment of cancer. It was the first system approved for clinical use in North America.

U.S. Computed Tomography (CT) Scanners Market

In 2026, the U.S. is anticipated to reach USD 1.62 billion, accounting for approximately 19.7% of the global sales.

To know how our report can help streamline your business, Speak to Analyst

Europe

Europe is projected to record a CAGR of 5.6% during the forecast period, making it the third-fastest-growing regional market. The market is expected to reach USD 1.40 billion in 2026. The growth is due to increasing awareness of early disease diagnosis among the population and well-established healthcare facilities in countries such as Germany, France, and Italy. Moreover, the rising focus of leading market players on expanding their geographical presence is further expected to propel market growth.

  • For instance, in 2023, GE HealthCare announced the establishment of a new CT scanner production line at its European headquarters in Buc, France. The company invested around USD 1.1 million in the facility, which became operational in 2024.

U.K. Computed Tomography (CT) Scanners Market

The U.K. market is projected to reach USD 0.06 billion in 2026, representing approximately 0.7% of the global revenues.

Germany Computed Tomography (CT) Scanners Market

The Germany market is expected to reach USD 0.30 billion in 2026, accounting for approximately 3.6% of the global revenues.

Latin America and Middle East & Africa

The Latin America market is estimated to reach approximately USD 1.05 billion in 2026. Growth is driven by increasing healthcare expenditure and rising investments by government organizations in the medical imaging industry.

  • For instance, in February 2024, Koning Health received regulatory clearance from the UAE’s Federal Authority for Nuclear Regulation (FANR) for its breast CT scanner. This approval would help the company to supply its breast CT scanners in the UAE.

The Middle East & Africa market is anticipated to grow at a moderate pace over the forecast period due to rising awareness of imaging technologies for early detection of various conditions, along with increasing investments encouraged by key players and governments in emerging countries across this region.

Saudi Arabia Computed Tomography (CT) Scanners Market

The Saudi Arabia market is estimated to reach approximately USD 0.06 billion in 2026, representing around 0.8% of the global revenues.

COMPETITIVE LANDSCAPE

Key Industry Players

Key Players are Expanding their Distribution Network to Strengthen their Market Position

The competitive landscape of the global market is consolidated, with a few dominant players, such as Siemens Healthineers AG, GE HealthCare, Canon Medical Systems Corporation, and Koninklijke Philips N.V. Ltd. Robust medical imaging portfolios, new product launches, and the presence of extensive distribution networks across all geographies are primarily responsible for these players’ dominance in the global computed tomography (CT) scanners market. Moreover, their rising emphasis on acquisitions and collaborations for the expansion of existing product portfolios across developing countries has further augmented their market share.

  • For instance, in December 2023, GE HealthCare showcased the Revolution Ascend CT scanner with AI-enabled software applications at the Radiological Society of North America (RSNA) 2023 annual meeting, highlighting its focus on workflow optimization.
  • For instance, in December 2023, Canon Medical Systems Corporation launched two of its four new artificial intelligence-based computed tomography scanners at the Radiological Society of North America (RSNA) 2023 annual meeting, strengthening its advanced diagnostic imaging portfolio.

Other key players, such as Hitachi, Ltd., Neusoft Medical Systems Co., Ltd., and Carestream Health, are also focusing on technological advancements in their imaging systems globally to deliver high-quality healthcare to the patient population, further propelling global market growth.

  • For instance, in January 2023, Carestream Health announced that it had been awarded 20 new patents during 2022 covering innovations in artificial intelligence (AI), image quality, and mobile imaging technologies. The innovation will fuel Carestream’s goals to deliver cutting-edge imaging solutions that enhance clinical decision-making and improve patient care.

LIST OF KEY COMPUTED TOMOGRAPHY (CT) SCANNERS COMPANIES PROFILED

KEY INDUSTRY DEVELOPMENTS

  • April 2026: Canon Medical launched Ultimion, Japan's first domestically developed photon-counting CT system. The platform is designed to deliver improved spatial resolution, enhanced spectral imaging capabilities, and lower radiation exposure compared with conventional CT technologies.
  • April 2026: GE HealthCare received FDA clearance for True Definition DL, a deep-learning CT image reconstruction solution. The technology improves image clarity, enhances diagnostic confidence, and supports dose optimization across a broad range of CT examinations.
  • January 2026: Planmeca introduced Planmeca Romexis 2D AI, expanding its artificial intelligence capabilities within dental imaging workflows. The software enhances diagnostic support and image interpretation while improving clinical efficiency for dental
  • December 2025: Neusoft Medical unveiled the NeuViz P10, the world's first 8 cm wide-coverage photon-counting CT scanner, at the RSNA annual meeting. The system incorporates advanced detector technology designed to improve spatial resolution, tissue characterization, and radiation dose efficiency.
  • November 2024: Royal Philips received U.S. FDA approval for its Spectral CT 7500 RT scanner, which is especially designed for respiratory-gated imaging. The scanner enables seamless integration into existing clinical workflows.
  • June 2024: FUJIFILM Healthcare Americas Corporation announced the launch of its new CT scanner, FCT iStream. This is a 128-slice scanner with capabilities of vision modelling along with iterative reconstructions.
  • November 2023: Siemens Healthineers AG launched ‘Somatom Pro.Pulse’, a dual-source computed tomography (CT) system with an integrated 3D camera for simplified patient positioning. The device consumes 20.0% less power and is more accessible for smaller and rural facilities and outpatient diagnostic centers.

REPORT COVERAGE

The research report provides a detailed analysis of the market for computed tomography (CT) scanners and focuses on key aspects such as leading companies, technology types, and leading product applications. Besides this, it offers insights into the market trends and highlights key industry developments. In addition to the aforementioned factors, the report encompasses several factors that have contributed to the growth and advancement of the market in recent years.

Request for Customization   to gain extensive market insights.


Report Scope & Segmentation

ATTRIBUTE  DETAILS
Study Period 2021-2034
Base Year 2025
Estimated Year  2026
Forecast Period 2026-2034
Historical Period 2021-2025
Growth Rate CAGR of 6.5% from 2026-2034
Unit Value (USD Billion)
Segmentation By Technology, Application, Modality, End-User, and Region
By Technology
  • High Slice
  • Mid Slice
  • Low Slice
  • Cone Beam Computed Tomography (CBCT)
By Application
  • Orthopedics
  • Cardiovascular
  • Oncology
  • Neurology
  • Others
By Modality 
  • O-arms
  • C-arms
By End-User
  • Hospitals & Ambulatory Surgical Centers (ASCs)
  • Diagnostic Imaging Centers
  • Others
By Region
  • North America (By Technology, By Application, By Modality, By End-User, and By Country)
    • U.S. (By Technology, By Application, By Modality, By End-User)
    • Canada (By Technology, By Application, By Modality, By End-User)
  • Europe (By Technology, By Application, By Modality, By End-User, and By Country)
    • U.K. (By Technology, By Application, By Modality, By End-User)
    • Germany (By Technology, By Application, By Modality, By End-User)
    • France (By Technology, By Application, By Modality, By End-User)
    • Italy (By Technology, By Application, By Modality, By End-User)
    • Spain (By Technology, By Application, By Modality, By End-User)
    • Russia (By Technology, By Application, By Modality, By End-User)
    • Rest of Europe (By Technology, By Application, By Modality, By End-User)
  • Asia Pacific (By Technology, By Application, By Modality, By End-User, and By Country)
    • China (By Technology, By Application, By Modality, By End-User)
    • India (By Technology, By Application, By Modality, By End-User)
    • Japan (By Technology, By Application, By Modality, By End-User)
    • South Korea (By Technology, By Application, By Modality, By End-User)
    • Australia (By Technology, By Application, By Modality, By End-User)
    • Rest of the Asia Pacific (By Technology, By Application, By Modality, By End-User)
  • Latin America (By Technology, By Application, By Modality, By End-User, and By Country)
    • Brazil (By Technology, By Application, By Modality, By End-User)
    • Mexico (By Technology, By Application, By Modality, By End-User)
    • Rest of Latin America (By Technology, By Application, By Modality, By End-User)
  • Middle East & Africa (By Technology, By Application, By Modality, By End-User, and By Country)
    • Saudi Arabia (By Technology, By Application, By Modality, By End-User)
    • Turkey (By Technology, By Application, By Modality, By End-User)
    • Rest of the Middle East & Africa (By Technology, By Application, By Modality, By End-User)


Frequently Asked Questions

Fortune Business Insights says that the global market was valued at USD 7.80 billion in 2025 and is projected to reach USD 13.63 billion by 2034.

Growing at a CAGR of 6.5%, the market is expected to exhibit steady growth over the forecast period (2026-2034).

By technology, the low slice segment led the market in 2025.

Rising burden of cancer, cardiovascular diseases, neurological disorders, and traumatic injuries are among the major factors driving market growth.

Siemens Healthineers AG, GE HealthCare, Canon Medical Systems Corporation, and Koninklijke Philips N.V. are the major players in the global market.

Asia Pacific dominated the market share in 2025.

Introduction of advanced imaging systems by market players is expected to drive the adoption of the product.

Seeking Comprehensive Intelligence on Different Markets?Get in Touch with Our Experts Speak to an Expert
  • 2021-2034
  • 2025
  • 2021-2024
  • 290
  • Buy Now

    (Offer valid till 15th Aug 2026)

Download Free Sample

    man icon
    Mail icon
Jump to Content

Get 30-60 hrs Free Customization

Expand Regional and Country Coverage, Segments Analysis, Company Profiles, Competitive Benchmarking, and End-user Insights.

Growth Advisory Services
    How can we help you uncover new opportunities and scale faster?
Healthcare Clients
3M
Toshiba
Fresenius
Johnson
Siemens
Abbot
Allergan
American Medical Association
Becton, Dickinson and Company
Bristol-Myers Squibb Company
Henry Schein
Mckesson
Mindray
National Institutes of Health (NIH)
Nihon Kohden
Olympus
Quest Diagnostics
Sanofi
Smith & Nephew
Straumann